was expressed in the logarithmic and stationary phase. The intracellular localization of I C h was different from that of I C . These findings provide insights into the physiological functions of I C h.
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1-3) Recent biochemical and mutational studies of I C4-9) and the crystal structure of I C in complex with CPY 9, 10) have shed light on its protease inhibition mode, in which the N-terminal acetyl group of I C is essential for its inhibitory function, and the inhibitor forms an equimolecular complex with the cognate protease through dual binding sites, the Nterminal inhibitory reactive site and the secondary CPYbinding site. 9) I C is encoded by the TFS1 (YLR178C) gene, and an adjacent gene, YLR179C, encodes a functionally unknown protein that has high homology with I C (Fig. 1) . We refer to the homologous protein as I C h.
Based on currently available data, I C and I C h appear to be members of the phosphatidylethanolamine-binding protein (PEBP) family. PEBPs are conserved among various organisms, from microorganisms to mammals. 4, 11) In addition, most organisms, including Saccharomyces cerevisiae, have multiple PEBPs. A variety of molecular functions of PEBP proteins in mammals have been reported to date, including association with phospholipids and membranes, [12] [13] [14] [15] inhibition of Raf-1 kinase, 16, 17) thrombin, 18) G-protein-coupled receptor kinase 2, 19) and the N-terminal fragment serving as a hippocampal cholinergic neurostimulating peptide. [20] [21] [22] Based on the crystal structure of bovine PEBP with phosphatidylethanolamine (PE), isolated as a cytoplasmic protein associated with PE, 13) it is suggested that a conserved anion-binding site might correspond to the recognition of PE, 23) but it was recently reported that the bovine PEBP bound not to PE-containing membranes but rather to anionic membranes containing phosphatidylglycerol.
15) It has also been indicated that I C specifically binds to membranes containing anionic phospholipids such as phosphatidylserine and phosphoinositides, and the phospholipid recognition of I C is attributable not to the conserved ligand binding site but to the N-terminal segment in its CPY-binding site and basic residues adjacent to the segment. 24) In plants, two homologs of PEBP from Arabidopsis thaliana, FLOWERING LOCUS T (FT) and TERMINAL FLOWER 1 (TFL1), have been identified as floral regulators that might interact with FD, a basic leucine zipper (bZIP) transcription factor, [25] [26] [27] [28] but little information on the biochemical characteristics and physical functions of I C h is available to date. In this study, to investigate the biochemical characteristics and physical functions of I C h, an overexpression y To whom correspondence should be addressed. Tel: +81-75-753-6110; Fax: +81-75-753-6112; E-mail: miueda@kais.kyoto-u.ac.jp Abbreviations: BTpNA, N-benzoyl-L-tyrosine-p-nitroanilide; bZIP, basic leucine zipper; CPY, carboxypeptidase Y; DTNB, 5,5-dithiobis-(2-nitrobenzoic acid); FM4-64, N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenylhexatrienyl) pyridinium dibromide; FT, FLOWERING LOCUS T; GFP, green fluorescent protein; I C , carboxypeptidase Y inhibitor; I C h, carboxypeptidase Y inhibitor homolog; PCMB, p-chloromercuribenzoic acid; PE, phosphatidylethanolamine; PEBP, phosphatidylethanolamine-binding protein; PMSF, phenylmethylsulfonyl fluoride; TFL1, TERMINAL FLOWER 1 system of I C h was constructed and recombinant I C h was purified and analyzed. The molecular mass and posttranslational modification were determined by MALDI-TOF MS analysis. The biochemical characterization of I C h was also undertaken by far-UV CD spectroscopic evaluation and chemical modification with sulfhydryl reagents. In addition, I
C h was analyzed from the viewpoint of a comparison with I C . Intracellular localization and transcriptional levels were compared. Based on these results, the putative function of I C h in the cell is proposed.
Materials and Methods

Construction of expression system for I
C h. The YLR179C gene encoding I C h was amplified from yeast genomic DNA using two oligonucleotides: 5 0 -CGC GGA TCC ATG TCT AGT GCC ATC G-3 0 and 5 0 -CCG GAA TTC CGG TTA CAT GTC ATA GTT G-3
0 . An approximately 600 bp fragment containing the YLR179C gene was excised by BamHI and EcoRI digestion, and inserted downstream of the GAL1 promoter in pYES2 (Invitrogen, San Diego, CA). The vector constructed was designated pYICH1 (Fig. 2A) . The sequence of the region of the YLR179C gene was confirmed with an ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA).
Saccharomyces cerevisiae strain BJ2168 (MAT prc1-407 prb1-1122 pep4-3 leu2 trp1 ura3-52 gal2) was transformed with pYICH1 using an EZ-Yeast Transformation Kit (Qbiogene, Carlsbad, CA). The transformants were isolated by plating on selective SD medium (0.67% w/v yeast nitrogen base without amino acids, 2% w/v glucose, and appropriate amino acids).
Expression and purification. The pYICH1 transformants were grown in YPGal medium (1% w/v yeast extract, 2% w/v peptone, and 2% w/v galactose) at 30 C. The harvested cells were suspended in 0.1 M sodium phosphate buffer (pH 7.0) containing 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 1 mg/ml pepstatin A, and disrupted by freeze-thawing. 5) After centrifugation, the supernatant, adjusted to a concentration of 1.0 M ammonium sulfate, was loaded onto a Butyl Toyopearl 650C (Tosoh, Tokyo) column (15 Â 40 mm) equilibrated with 0.1 M sodium phosphate buffer (pH 7.0) containing 1 M ammonium sulfate, 1 mM EDTA and 1 mM DTT. I C h was eluted with 0.1 M sodium phosphate buffer (pH 7.0). The fraction containing I C h was concentrated by ultrafiltration and loaded onto a DEAE Sephadex A- 50 (Amersham Biosciences, Uppsala, Sweden) column (30 Â 60 mm) equilibrated with 10 mM sodium phosphate buffer (pH 7.0) containing 1 mM EDTA, and 1 mM DTT. I C h was eluted with the equilibrated buffer containing 0.2 M NaCl and concentrated by ultrafiltration. The I C h solution was applied to a Superdex 75 column (Amersham Biosciences, 10 Â 300 mm) equilibrated with 0.1 M sodium phosphate buffer (pH 7.0) containing 0.15 M NaCl, 1 mM EDTA, and 1 mM DTT, and eluted with the same buffer. The eluted fraction was used as purified I C h. I C was produced using the yeast Saccharomyces cerevisiae expression system and purified by the method described previously.
5)
N-Terminal sequencing. Purified I C h (5mM) was subjected to SDS-PAGE and blotted on to a PVDF membrane. The putative I C h band was cut off, and the PVDF membrane piece was analyzed with a protein sequencer, ABI model 476A (Applied Biosystems).
Mass spectrometry. The molecular mass of I
C h and the peptide fragments obtained by tryptic digestion were determined by MALDI-TOF MS using a Voyager RP (Applied Biosystems). Samples were prepared as follows: 50 mM I C h was desalted with ZipTip C4 (Millipore, Bedford, MA), and eluted with 50% (v/v) acetonitrile containing 10 mg/ml 3,5-dimethoxy-4-hydroxy cinnamic acid and 0.1% (v/v) trifluoroacetic acid. For the fragmentation of I C h, 50 mM I C h was digested to peptides with trypsin at 37 C for 16 h. The peptides were desalted with ZipTip C18 (Millipore), and eluted with 60% (v/v) acetonitrile containing 10 mg/ml -cyano-4-hydroxycinnamic acid and 0.1% (v/v) trifluoroacetic acid. Data were calibrated with standard proteins (bovine trypsinogen and horse apomyoglobin) or peptides (bovine insulin B chain, oxidized, and human angiotensin II).
Circular dichroism spectroscopy. The CD spectrum in the region 200-260 nm was measured in a cell with an optical pathlength of 0.1 cm at 25 C with a Jasco J-720W spectropolarimeter (Jasco, Tokyo). The concentration of I C h was 10 mM in 0.1 M sodium phosphate buffer (pH 7.0). The CD spectrum was deconvoluted using the CDFIT program.
29)
Titration of SH groups. Free sulfidryl groups of I C h were determined by titration with DTNB and PCMB. 30, 31) Five micromolar DTNB was mixed with 20 mM I C h in 20 mM sodium phosphate buffer (pH 8.0) containing 1 mM EDTA and 0.5% (w/v) SDS, and incubated at 25 C for 1 h. The absorbance at 412 nm was followed. Forty micromolar PCMB was mixed with 20 mM I C h in 50 mM sodium phosphate buffer (pH 7.0) containing 0.5% (w/v) SDS, and incubated at 25 C for 1 h. The absorbance at 255 nm was followed. In both cases, the numbers of sulfhydryl groups were calculated by comparison with the results of the same titrations using a standard, cysteine.
Inhibitory activity of I
C h. The inhibitory activity of I C h to CPY was determined as the residual activity of CPY with respect to the hydrolysis of 0.3 mM Nbenzoyl-L-tyrosine-p-nitroanilide (BTpNA) in 0.1 M sodium phosphate buffer (pH 7.0). 32) Various quantities of I C h were mixed with 2 mg of CPY, and the mixtures were incubated at 37 C for 5 min.
Gel filtration analysis. The interactions between CPY and I
C h and I C were analyzed by gel filtration with a Superdex 75 column (10 Â 300 mm). Equilibration and elution were carried out with 0.1 M sodium phosphate buffer (pH 7.0) containing 0.15 M NaCl, 1 mM EDTA, and 1 mM DTT at a flow rate of 0.5 ml/min. CPY (100 mg, 11 mM final concentration) and I C h (36.4 mg, 11 mM) or I C (40 mg, 11 mM) were mixed and subjected to chromatography.
Northern hybridization. Total RNA was extracted from yeast cells with ISOGEN-LS (Nippon Gene, Tokyo). mRNA was purified from total RNA using an Oligotex dT30 mRNA Purification kit (Takara, Tokyo). After agarose gel electrophoresis of the purified mRNA under denaturing conditions, the gel was used for blotting onto a positively charged membrane, Hybond-N þ (Amersham Biosciences). YLR179C (I C h) and TFS1 (I C ) were amplified with PCR. The amplified products were labeled with an AlkPhos Direct Labelling Kit (Amersham Biosciences), and then hybridized to the mRNA on the membranes at 55 C for 16 h. Chemiluminescence from the labeled probes was detected using X-ray film.
Analysis of intracellular localization. To produce GFP-fused I C h (I C h-GFP), a DNA fragment encoding GFP was inserted downstream of the I C h-encoding gene in pYICH1, and Saccharomyces cerevisiae strain BY4741ichÁ (MATa ylr178c::kanMX4 his3 leu2 met15 ura3) (Euroscarf, Frankfurt, Germany) was transformed with the generated vector. GFP-fused I C (I C -GFP) was produced using pYTF1 5) and S. cerevisiae strain BY4741icÁ (MATa ylr178c::kanMX4 his3 leu2 met15 ura3) (Euroscarf, Frankfurt, Germany), as described above. These transformed cells were grown to the earlystationary phase in SD medium. The cultured cells were then suspended at an OD 600 of 1.0-1.2 in nutrient-rich YPGal medium containing 1 mg/ml N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenylhexatrienyl) pyridinium dibromide (FM4-64), a fluorescent dye for staining vacuolar membranes. During cultivation at 30 C for 72 h, the labeled cells producing I C h-GFP or I C -GFP were harvested at the logarithmic and stationary growth phases and resuspended in the same medium at an OD 600 of 100-200. Fluorescence images of the resuspended cells were obtained using an IX71 inverted microscope (Olympus, Tokyo).
Results
Biochemical characterization of I
C h The expression level of the I C h gene (I C h) was increased after induction by galactose. By induction using galactose, a protein in the vicinity of 25 kDa was detected notably in SDS-PAGE analysis. The 25 kDa protein was assumed to be I C h, and each purification step was evaluated by SDS-PAGE. In the final purification, 20 mg of I C h was obtained from 100 g of wet yeast cells. Homogeneity was confirmed by SDS-PAGE (Fig. 2B) . The molecular mass of I C h was determined to be 22,033.7 by MALDI-TOF MS (Fig. 3A) , smaller than the putative molecular mass. The presence of post-translational modification was investigated by MS analysis of a tryptic digestion of I C h (Fig. 3B and Table 1 ). The masses of peptides corresponding to residue numbers 9 to 201 were almost all detected, but the mass of the N-terminal peptide, 806.4 for residue numbers 1-8 was not. In yeast, a subset of proteins with Met-Asn-termini like I C are acetylated Met1, whereas almost all proteins with Met-Ser-termini are Nterminal-acetylated after the cleavage of Met1. 33) Since I C h has a Met-Ser-terminus, we predicted that such a modification might occur. In mass analysis of Ac-Ser-N-terminal peptide, 717.4 was detected. Hence we concluded that the cleavage of Met1 and sequential acetylation of Ser2 constituted post-translational modification in I C h. This is consistent with the result of Nterminal sequencing, in which the N-terminus was blocked.
The secondary structure of I C h was calculated from the far-UV CD spectrum (data not shown): the -helix content was 10.0%, and the -sheet was 47.8%. This indicates that I C h is a -type protein in which astructure is the predominant structural element. Titrations of SH groups revealed that I C h contains two SH groups (data not shown). Although two cysteine residues were present, I
C h contained no disulfide bond. Since I C is also a -type protein and has no disulfide bond, the features of I C h are similar to those of I C .
Comparison of I C h and I
C
The inhibitory activity of I C h toward CPY was examined (Fig. 4) , since I C is a CPY inhibitor. The residual activity of CPY in the presence of I C h was measured. No inhibition was found even at a 140-fold molar excess of I C h, whereas a 5-fold molar excess of I C almost completely inhibited the activity.
5) This result indicates that I
C h has no inhibitory activity toward CPY, as opposed to I C . However, the possibility that I C h interacts with CPY, with no inhibition, cannot be excluded, and so the interaction between I C h and CPY was examined by gel filtration analysis (data not shown). Equivalent molar mixtures of I C h and CPY or I C and CPY were analyzed by Superdex 75 gel filtration chromatography. Two peaks, corresponding to I C h and CPY, were detected in the mixture of I C h and CPY, whereas one peak corresponding to a complex of I C and CPY was detected in the mixture of I C and CPY (data not shown). These results indicate that I C h does not interact with CPY.
Transcriptional levels of I C h and I C were analyzed by northern hybridization (Fig. 5) . I C h is expressed mainly in the early log phase, whereas I C is expressed in the stationary phase. Transcriptions of I C h and I C do not occur simultaneously. GFP fusion proteins revealed the intracellular localizations of I C h. The yeast cells were also labeled with a fluorescent dye that stains vacuolar membranes, FM4-64, which was taken up by endocytosis. I C h-EGFP indicated that I C h is localized in the cytoplasm in the logarithmic growth phase, and it almost disappeared in the stationary growth phases (Fig. 6 ).
Discussion
Biochemical characterization of I C h An overexpression system for I C h was constructed using a vector containing the GAL1 promoter and a proteinase A-, B-and CPY-deficient strain of Saccha-romyces cerevisiae, BJ2168. We purified I C h by chromatography and identified it by mass spectroscopy.
MALDI-TOF MS analysis revealed that I
C h is modified post-translationally: cleavage of Met1 and sequential acetylation of Ser2 (Table 1) . In I C , the acetylation of Met1 is by post-translational modification. 7, 8) This difference is related to the difference in the N-terminal amino acid sequence. In a subclass of proteins with MetSer-termini like I C h, Ser2 is acetylated by N-terminal acetyltransferase A (NatA) after the cleavage of Met1, whereas in a subclass of proteins with Met-Asn-termini like I C , Met1 is acetylated directly by NatB. 8, 33) Since acetylation of I C is crucial for its inhibitory activity toward CPY, 7) it is possible that post-translational 
modification of I
C h is also important for the function of I C h. I C h is folded as a monomeric -protein and lacks disulfide bonds, as determined by gel filtration, far-UV CD spectroscopical evaluation, and chemical modification with sulfidryl reagents. These features are similar to those of reported proteins in the PEBP family, including I C .
11)
Comparison of properties of I C h and I
C
We analyzed the properties of I C h and compared them with those of I C . The inhibitory activity of I C h toward CPY and the interaction between I C h and CPY were examined (Fig. 4) . When a 140-fold molar excess of I C h was added, CPY activity was not inhibited at all. The fact that a 5-fold molar excess of I C inhibits the activity by more than 95% 5) indicates that I C h has no inhibitory activity toward CPY. The interaction between I C h and CPY was also examined by gel filtration chromatography (data not shown). No peak corresponding to a complex was detected. Hence we conclude that I C h does not form a complex with CPY.
The transcriptional level of I C h is distinct from that of I C . I C h is highly transcribed in the early log phase, but the I C h transcript almost disappeared in the stationary phase, in which I C is highly transcribed (Fig. 5) . GFP fusion proteins revealed that I C h is exclusively localized in the cytoplasm (Fig. 6) . However, I
C in the cytoplasm at the logarithmic growth phase is selectively translocated into the vacuolar membranes and lumens during the stationary phase. The results of localization were obtained from GFP fusion proteins overexpressed by galactose-induction. However, I
C was isolated as a cytoplasmic protein, whereas I C inhibits vacuolar proteinase CPY. This evidence indicates that endogeneous I C is also able to localize at the vacuolar membrane and lumens. These results suggest that the physiological functions of I C h are different from those of I C .
I C h belongs to the PEBP family I C h and I C are not members of a known protease inhibitor family, but rather of the phosphatidylethanolamine-binding protein (PEBP) family. Amino acid sequence alignments of I C , I C h and its homologs from humans are shown in Fig. 1B . PEBPs are classified into a short-length (small size, about 21 kDa) type and longlength (large size, about 23 kDa) type. I C h and human PEBP (hPEBP) are of the short-length type, and I C and the human PEBP family protein precursor (hpPEBP) are of the long-length type. Both PEBP types are produced in the same organism. In the sequences, the N-termini are characteristic. Short-length type PEBPs lack Nterminal 6-11 amino acids, as compared with long-type proteins. It has been reported that the N-terminal 7 amino acids of I C are crucial for inhibitory activity toward CPY. 9) That I C h lacks N-terminal 7 amino acids might be responsible for non-inhibitory activity toward CPY.
The PEBP family is a protein group having sequence homology. Its protein structures are conserved well for overall structure. 9, 23, [34] [35] [36] However, a variety of molecular functions of PEBP proteins have been reported to date, and these molecular mechanisms and the relationships among them remain obscure. In each organism, there exist PEBPs which have slightly different sequences, especially at the terminal regions. 35, 36) Only in plants, it was reported that the two homologues of PEBPs from Arabidopsis, FT and TFL1, act as flowering regulators. They act in an opposite manner: FT is an activator and TFL1 is a repressor. [25] [26] [27] [28] 37) However, they act in an opposite manner: FT is an activator and TFL1 is a repressor. I C and I C h are also homologs of PEBPs from Saccharomyces cerevisiae, and it has been reported that I C inhibited and interacted with the yeast Ras GTPase-activating protein, Ira2p. 38) Preliminary experiments, in which I C h-associated proteins were screened by the two-hybrid method and affinity chromatography, have been carried out, and several proteins that are involved in signal transduction were screened (data not shown). Some of these were closely related to the Ras/ cAMP signaling pathway, which I C affects by regulating Ira2p. Based on these results, this study indicates the possibility that the two homologues of PEBPs from Saccharomyces cerevisiae, I
C and I C h, act on the Ras signal pathway and function in an interdependent manner. Further detailed studies would reveal the physiological functions of I C h. In conclusion, we isolated a CPY inhibitor (I C ) homolog I C h, and its biochemical properties were examined. The data obtained suggest that the physiological functions of I C h are different from that of I C . These findings provide insights into the novel functions of, not only I C h and I C , but other PEBPs as well. C h) and TFS1 (encoding I C ). After agarose gel electrophoresis of the mRNAs under denaturing conditions, the gel was blotted. The blot was hybridized with I C h, I C , and ACT1 (loading control) probes.
